SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-019342
Filing Date
2024-07-08
Accepted
2024-07-08 16:30:11
Documents
1
Period of Report
2024-02-19

Document Format Files

Seq Description Document Type Size
1 form4-07082024_040707.html 4  
1 form4-07082024_040707.xml 4 6933
  Complete submission text file 0001415889-24-019342.txt   8469
Mailing Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 805-267-9889
GENELUX Corp (Issuer) CIK: 0001231457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GENELUX CORPORATION 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address
Ryder Sean (Reporting) CIK: 0001937485 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41599 | Film No.: 241105071